Screen of DM by OGTT in Subjects Receiving CAG or MDCT for CAD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01198730|
Recruitment Status : Recruiting
First Posted : September 10, 2010
Last Update Posted : September 13, 2017
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus Coronary Artery Disease||Drug: Acarbose||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2000 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Screen of Diabetes Mellitus by Oral Glucose Tolerance Test in Subjects Receiving Catheterization or Multi-detector Computed Tomography (MDCT) for Coronary Artery Disease|
|Study Start Date :||April 2009|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
Acarbose for DM patient with HbA1c > 6.5%. Add on sitagliptin if HbA1c > 7.0% after 26 weeks.
Acarbose 25 mg tid, titrate to 100 mg tid.
Other Name: Glucobay
- HbA1c and results of meal tolerance test [ Time Frame: 52 weeks ]Patient who was diagnosed with DM after an OGTT was asked to follow up HbA1c after 6-12 months. Acarbose was given for those who had HbA1c > 6.5%. After 26 weeks, sitagliptin was given for those who had HbA1c > 7.0%.
- Hypoglycemia [ Time Frame: 52 weeks ]Symptoms of hypoglycemia or glucose value below 70 mg/dl after treatment with acarbose
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01198730
|Taichung Veterans General Hospital||Recruiting|
|Taichung, Taiwan, 40705|
|Contact: Wayne H-H Sheu, MD, PHD firstname.lastname@example.org|
|Principal Investigator:||Wayne H-H Sheu, MD, PHD||Taichung Veterans General Hospital|